Table of Contents
Research & Development
| Janssen Biotech Bolsters Immuno-Oncology Pipeline with Xencor’s Bispecific Antibodies | Abstract pdf html |
| Lucy Haggerty |
Mergers & Acquisitions
| Acquisition of Antibody Specialist Teneobio for US$2.5 B by Amgen | Abstract pdf html |
| Ashish Tripathi |
| Merck & Co. Gets Sotatercept with US$11.5 B Acceleron Buyout | Abstract pdf html |
| Sasha Yachu |
This work is licensed under a Creative Commons Attribution 3.0 License.